SAStefanos Adamis

Stefanos Adamis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Stefanos Adamis has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Constantinos A. Constantinides

    1st Department of Urology, Athens Medical School, “Laiko” Hospital, Athens, Greece

    1 shared publication
  • I.M. Varkarakis

    2nd Department of Urology, University of Athens, Medical School, Sismanoglion Hospital, Athens, Greece

    1 shared publication
  • John Varkarakis

    1 shared publication
  • Konstantinos G. Stravodimos

    1st Department of Urology, Athens Medical School, Laiko Hospital, Athens, Greece

    1 shared publication
  • Stavros Tyritzis

    1st Department of Urology, Athens Medical School, “Laiko” Hospital, Athens, Greece

    1 shared publication
  • Zavos Georgios

    Transplantation Unit, “Laiko” Hospital, Athens, Greece

    1 shared publication

Latest Publications

  • Renal Transplant Lithiasis: Analysis of Our Series and Review of the Literature

    by Konstantinos G. Stravodimos, Stefanos Adamis, Stavros Tyritzis, Zavos Georgios, Constantinos A. Constantinides

    Background and Purpose: Renal transplant lithiasis represents a rather uncommon complication. Even rare, it can result in significant morbidity and a devastating loss of renal function if obstruction occurs. We present our experience with graft lithiasis in our series of renal transplantations and review the literature regarding the epidemiology, pathophysiology, and current therapeutic strategies in the management of renal transplant lithiasis. Patients and Methods: In a retrospective analysis of a consecutive series of 1525 renal transplantations that were performed between January 1983 and March 2007, 7 patients were found to have allograft lithiasis. In five cases, the calculi were localized in the renal unit, and in two cases, in the ureter. A review in the English language was also performed of the Medline and PubMed databases using the keywords renal transplant lithiasis, donor-gifted lithiasis, and urological complications after kidney transplantation. Several retrospective studies regarding the incidence, etiology, as well as predisposing factors for graft lithiasis were reviewed. Data regarding the current therapeutic strategies for graft lithiasis were also evaluated, and outcomes were compared with the results of our series. Results: Most studies report a renal transplant lithiasis incidence of 0.4% to 1%. In our series, incidence of graft lithiasis was 0.46% (n=7). Of the seven patients, three were treated via percutaneous nephrolithotripsy (PCNL); in three patients, shockwave lithotripsy (SWL) was performed; and in a single case, spontaneous passage of a urinary calculus was observed. All patients are currently stone free but still remain under close urologic surveillance. Conclusion: Renal transplant lithiasis requires vigilance, a high index of suspicion, prompt recognition, and management. Treatment protocols should mimic those for solitary kidneys. Minimally invasive techniques are available to remove graft calculi. Long-term follow-up is essential to determine the outcome, as well as to prevent recurrence.


  • Minimally invasive approach in the management of upper- urinary-tract tumours

    by Stefanos Adamis, John Varkarakis

    Nephroureterectomy with bladder cuff excision has been the gold standard treatment for upper tract transitional cell carcinoma (UTTCC) for more than 60 years. However, endoscopic treatment of urothelial tumours of renal pelvis and ureter is gaining acceptance as a conservative treatment modality. A review in the English language of the Medline and Pub Med databases was performed using the keywords upper urinary tract transitional cell carcinoma and endoscopic management. There was a particular emphasis on treatment outcomes from published series. Endoscopic treatment of UTTCC alone for high-grade tumours is not advised owing to high rates of both local recurrence and disease progression, while many authors do not recommend primary endoscopic management of UTTCC in elective situations if pathological analysis and tumour grade cannot be obtained. Endourological management of UTTCC has become an accepted treatment option in highly selected patients, provided long-term close surveillance to detect and treat recurrences is ensured.